Dr. Meg Richards has over 20 years' experience as an epidemiologist in the public health, biopharma, and contract research sectors. Prior to joining PPD as Executive Director of Epidemiology & Health Outcomes, Meg served as Director of Global Patient Safety & Risk Management at Genzyme Corporation.
Dr. Meg Richards has over 20 years' experience as an epidemiologist in the public health, biopharma, and contract research sectors. Prior to joining PPD as Executive Director of Epidemiology & Health Outcomes, Meg served as Director of Global Patient Safety & Risk Management at Genzyme Corporation.
Dr. Irizarry is Director and Therapy Area Lead, Neurosciences and Infectious Disease Epidemiology at GSK. He is an epidemiologist and neurologist, who joined GSK in 2006 with a clinical and research background in neurodegenerative diseases and biomarkers.
Description
Three speakers from the industry/CRO setting who have successfully integrated epidemiology into their product development programs will describe this integration from a structural and functional viewpoint, as well as share best practices for leveraging epidemiologic talent. The session includes a description of a typical 'day in the life' of an industry- or CRO-located epidemiologist.
Learning Objectives: Identify the potential role and contributions of an epidemiologist in the industry or CRO setting Define the best practices in organizational structure and function that support the successful integration of epidemiology into product development